Broad Network Reach CoverMyMeds network spans 350+ EHRs, 50,000+ pharmacies, 950,000+ providers, and major health plans and PBMs, offering a robust platform for selling interoperability, automated prior authorization, and patient access solutions to large health systems.

Specialty Access Growth The March 9, 2026 launch of expanded Specialty Access and Affordability Solutions signals a strategic pivot to speed therapy starts and reduce out-of-pocket burden, creating upsell opportunities with providers, payers, and specialty clinics seeking faster, more affordable access.

Payer Integration Momentum Recent payer-focused moves, including Regence's GLP-1 prior authorizations integration (Dec 2025) and partnerships with Surescripts and Makineros, demonstrate a proven pathway for expanding ePA workflows across additional payers and benefit designs.

Acquisition Synergy The 2025 RxLightning acquisition enhances digital prior authorization and ePA capabilities, enabling cross-sell of end-to-end access workflows and specialty drug programs to existing clients and new health systems.

Enterprise Scale Advantage As a McKesson subsidiary with substantial revenue and enterprise reach, CoverMyMeds is positioned to co-sell with other McKesson offerings and target large health systems, while leveraging existing technology stack and data governance capabilities to streamline deployments.